Table 2.
Nuclei | Pre (SD) | PBwk2 (SD) | PBwk4 (SD) |
---|---|---|---|
DCN | 0.956 (.232) | 1.014 (.347) (F(2,81)=2.352, p>0.05) |
1.127 (.310) (F(2,81)=2.352, p>0.05) |
IC | 0.553 (.098) | 0.545 (.113) (F(2,81)=0.721, p>0.05) |
0.598 (.269) (F(2,81)=0.721, p>0.05) |
MGB | 0.476 (.113) | 0.520 (.167) (F(2,81)=0.664, p>0.05) |
0.510 (.163) (F(2,81)=0.664, p>0.05) |
AC | 0.525 (.093) | 0.520 (.093) (F(2,81)=0.183, p>0.05) |
0.535 (.084) (F(2,81)=0.183, p>0.05) |
AMG | 0.534 (.140) | 0.475 (.134) (F(2,81)=1.727, p>0.05) |
0.529 (.119) (F(2,81)=1.727, p>0.05) |
CC | 0.420 (.206) | 0.439 (.237) (F(2,203)=0.296, p>0.05) |
0.448 (.210) (F(2,203)=0.296, p>0.05) |
p<0.05.
Changes in RD across nuclei between pre- and post-blast weeks 2 and 4. No significant changes in RD were found in either the auditory or non-auditory structures. ANOVA and post-hoc Bonferroni tests.
MGB, medial geniculate body; ANOVA, analysis of variance; IC, inferior colliculus; CC, corpus callosum; AMG, amygdala; DCN, dorsal cochlear nucleus; SD, standard deviation; Pre, pre-blast; PBwk2, post-blast week 2; PBwk4, post-blast week 4.